documents: FDA-2021-D-0669-0008
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-D-0669-0008 | FDA | FDA-2021-D-0669 | S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals; International Council for Harmonisation; Guidance for Industry; Availability | Notice | Notice of Availability | 2022-11-02T04:00:00Z | 2022 | 11 | 2022-11-02T12:34:04Z | 2022-23787 | 0 | 0 | 090000648547b3db |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref